title: [Association of hemoglobinopathy and alpha thalassemia. Study of 45 patients].
abstract: OBJECTIVE
  Hemoglobin S (HbS) alpha-thalassemia together with ss-thalassemia and hemoglobins C, E and D are named common hemoglobinopathies. In this study, we analyzed the frequency of the association between alpha-thalassemia and HbS and its phenotypic expression.
  
  
  METHODS
  Since January 1995 to March 2003 we studied 83 cases of HbS, which were diagnosed by electrophoretic and chromatographic criteria. The molecular study was carried out by Southern blot with the restriction enzymes Bam HI and Bgl II and a (1.5 Kb Pst) and z (1.8 Kb Sac Y) probes.
  
  
  RESULTS
  45 cases (54.2%) had a-thalassemia (36 -alpha3,7/aa; 1-alpha4,2/alphaalpha; 6 -alpha3,7/-alpha3,7; 1-alpha4,2/-alpha4,2); 36 had not alpha-thalassemia and in two cases there were a triplication of a genes. The patients with HbS heterozygote associated with alpha-thalassemia showed a percentage of HbS (p < 0.0001), CMV (p = 0.004), MCH (p = 0.002) and MCHC (p = 0.02) significantly lower than the cases of HbS without this association. However, no differences between both groups were found with regard to the rest of parameters analyzed (Hb p = 0.56; PVC p = 0.84; RDW p = 0.06; Reticulocytes p = 0.26; HbF p = 0.76; HbA2 p = 0.13). In the cases with a severe form of disease (HbS homozygote; HbS/Hb C; HbS/beta-thalassemia), patients with alpha-thalassemia had a number of leukocytes that was significantly lower than that of patients without alpha-thalassemia (p = 0.034).
  
  
  CONCLUSIONS
  An association between HbS and alpha-thalassemia was common (> 50%). Screening for this association is of great interest because the clinical expression in the cases of HbS homozigote will be modulated. This association must be suspected in cases of homozygous HbS in which levels of HbS are lower than expected.
authors.affiliation: Servicio de Hematología y Hemoterapia, Hospital Clínico San Carlos, Madrid, España. fgonzalezf@aehh.org
authors.forename: Fernando
authors.initials: F
authors.lastname: Ataulfo González
authors.forename: Cristina
authors.initials: C
authors.lastname: Blázquez
authors.forename: Paloma
authors.initials: P
authors.lastname: Ropero
authors.forename: Olga
authors.initials: O
authors.lastname: Briceño
authors.forename: Concha
authors.initials: C
authors.lastname: Alaez
authors.forename: Marta
authors.initials: M
authors.lastname: Polo
authors.forename: Celina
authors.initials: C
authors.lastname: Benavente
authors.forename: Marta
authors.initials: M
authors.lastname: Mateo
authors.forename: Ascensión
authors.initials: A
authors.lastname: Peña
authors.forename: Ana
authors.initials: A
authors.lastname: Villegas
mesh_terms: D000755:Anemia, Sickle Cell / Q000235:genetics*; D006453:Hemoglobinopathies / Q000235:genetics; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D010641:Phenotype; D013030:Spain; D017085:alpha-Thalassemia / Q000235:genetics*